U.S. Global Investors (USGI)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,279
Closed -$334K 176
2020
Q4
$334K Hold
4,279
0.01% 111
2020
Q3
$339K Hold
4,279
0.02% 91
2020
Q2
$316K Buy
4,279
+996
+30% +$75K 0.03% 106
2020
Q1
$241K Sell
3,283
-1,900
-37% -$149K 0.06% 114
2019
Q4
$450K Hold
5,183
0.2% 117
2019
Q3
$416K Buy
+5,183
New +$415K 0.23% 113
2015
Q3
Sell
-4,716
Closed -$256K 345
2015
Q2
$256K Hold
4,716
0.1% 175
2015
Q1
$259K Hold
4,716
0.07% 202
2014
Q4
$256K Buy
+4,716
New +$263K 0.07% 178
2014
Q2
Sell
-4,506
Closed -$244K 344
2014
Q1
$244K Buy
+4,506
New +$233K 0.04% 220
2013
Q4
Sell
-6,456
Closed -$293K 350
2013
Q3
$293K Buy
6,456
+1,216
+23% +$55.5K 0.05% 186
2013
Q2
$232K Buy
+5,240
New +$234K 0.04% 201

Other funds holding MRK

U.S. Global Investors (USGI)'s MRK Position: Q1 2021 in Review

U.S. Global Investors (USGI) sold out of Merck (MRK) in Q1 2021, closing a stake of 4,279 shares — an estimated $334K sold.

U.S. Global Investors (USGI) first reported a position in MRK in Q2 2013 and held it in 12 quarters. The position peaked at $450K in Q4 2019. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • U.S. Global Investors (USGI) reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 4,279 Merck shares in Q1 2021, an estimated $334K.
  • U.S. Global Investors (USGI) first reported a position in Merck in Q2 2013 and held it in 12 quarters.
  • U.S. Global Investors (USGI)'s Merck position peaked at $450K in Q4 2019.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2021, filed 23 Apr 2021.